Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash-to-Debt 0.21
LHCG's Cash-to-Debt is ranked lower than
61% of the 266 Companies
in the Global Medical Care industry.

( Industry Median: 0.48 vs. LHCG: 0.21 )
Ranked among companies with meaningful Cash-to-Debt only.
LHCG' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.01  Med: 0.45 Max: No Debt
Current: 0.21
Equity-to-Asset 0.63
LHCG's Equity-to-Asset is ranked higher than
69% of the 262 Companies
in the Global Medical Care industry.

( Industry Median: 0.48 vs. LHCG: 0.63 )
Ranked among companies with meaningful Equity-to-Asset only.
LHCG' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.34  Med: 0.72 Max: 0.82
Current: 0.63
0.34
0.82
Interest Coverage 25.55
LHCG's Interest Coverage is ranked higher than
70% of the 223 Companies
in the Global Medical Care industry.

( Industry Median: 8.41 vs. LHCG: 25.55 )
Ranked among companies with meaningful Interest Coverage only.
LHCG' s Interest Coverage Range Over the Past 10 Years
Min: 18.3  Med: 35.04 Max: 713.45
Current: 25.55
18.3
713.45
Piotroski F-Score: 4
Altman Z-Score: 5.80
Beneish M-Score: -2.70
WACC vs ROIC
6.56%
10.51%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating Margin % 7.70
LHCG's Operating Margin % is ranked higher than
52% of the 267 Companies
in the Global Medical Care industry.

( Industry Median: 7.39 vs. LHCG: 7.70 )
Ranked among companies with meaningful Operating Margin % only.
LHCG' s Operating Margin % Range Over the Past 10 Years
Min: -1.01  Med: 8.33 Max: 15.99
Current: 7.7
-1.01
15.99
Net Margin % 4.09
LHCG's Net Margin % is ranked lower than
52% of the 268 Companies
in the Global Medical Care industry.

( Industry Median: 4.40 vs. LHCG: 4.09 )
Ranked among companies with meaningful Net Margin % only.
LHCG' s Net Margin % Range Over the Past 10 Years
Min: -2.09  Med: 4.15 Max: 10.95
Current: 4.09
-2.09
10.95
ROE % 10.00
LHCG's ROE % is ranked higher than
52% of the 251 Companies
in the Global Medical Care industry.

( Industry Median: 9.35 vs. LHCG: 10.00 )
Ranked among companies with meaningful ROE % only.
LHCG' s ROE % Range Over the Past 10 Years
Min: -4.93  Med: 10.04 Max: 26.16
Current: 10
-4.93
26.16
ROA % 6.24
LHCG's ROA % is ranked higher than
65% of the 270 Companies
in the Global Medical Care industry.

( Industry Median: 3.85 vs. LHCG: 6.24 )
Ranked among companies with meaningful ROA % only.
LHCG' s ROA % Range Over the Past 10 Years
Min: -3.51  Med: 6.61 Max: 20.02
Current: 6.24
-3.51
20.02
ROC (Joel Greenblatt) % 71.30
LHCG's ROC (Joel Greenblatt) % is ranked higher than
83% of the 270 Companies
in the Global Medical Care industry.

( Industry Median: 16.38 vs. LHCG: 71.30 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
LHCG' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -4.82  Med: 63.16 Max: 147.21
Current: 71.3
-4.82
147.21
3-Year Revenue Growth Rate 10.40
LHCG's 3-Year Revenue Growth Rate is ranked higher than
61% of the 193 Companies
in the Global Medical Care industry.

( Industry Median: 7.90 vs. LHCG: 10.40 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
LHCG' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 3.5  Med: 20.5 Max: 60.7
Current: 10.4
3.5
60.7
3-Year EBITDA Growth Rate 13.40
LHCG's 3-Year EBITDA Growth Rate is ranked higher than
66% of the 170 Companies
in the Global Medical Care industry.

( Industry Median: 7.90 vs. LHCG: 13.40 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
LHCG' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -64.8  Med: 28.7 Max: 171.3
Current: 13.4
-64.8
171.3
3-Year EPS without NRI Growth Rate 16.80
LHCG's 3-Year EPS without NRI Growth Rate is ranked higher than
67% of the 144 Companies
in the Global Medical Care industry.

( Industry Median: 7.90 vs. LHCG: 16.80 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
LHCG' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -21.4  Med: 24.8 Max: 112.8
Current: 16.8
-21.4
112.8
GuruFocus has detected 4 Warning Signs with LHC Group Inc $LHCG.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» LHCG's 30-Y Financials

Financials (Next Earnings Date: 2017-08-03 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care    NAICS: 621610    SIC: 8082
Compare:NAS:SGRY, NYSE:CYH, NAS:TVTY, NAS:AFAM, NYSE:USPH, NYSE:AMN, NAS:PRSC, NYSE:THC, NYSE:SEM, OTCPK:RLGHF, OTCPK:CGMVF, NAS:ADUS, OTCPK:MFCSF, NAS:BIOS, NAS:AMED, OTCPK:LTGHY, NAS:SCAI, NYSE:AAC, NYSE:CCM, NYSE:QHC » details
Traded in other countries:LH6.Germany,
Headquarter Location:USA
LHC Group Inc provides post-acute health care services to patients through its home nursing agencies, community-based services agencies, hospice agencies and long-term acute care hospitals.

LHC Group Inc was incorporated on February 9, 2005. The Company provides post-acute health care services to patients through its home nursing agencies, community-based services agencies, hospice agencies and long-term acute care hospitals (LTACHs). The Company through its wholly- and majority-owned subsidiaries, equity joint ventures and controlled affiliates, operates in 30 states within the continental United States. The Company operates in three segments: home-based services, hospice services and facility-based services. In the home-based services segment, the Company provides home-based post-acute health care services through its home nursing and community-based agencies. Its service locations offer services, including skilled nursing, community-based nursing and companion services, non-skilled community-based services (CBS), medically-oriented social services and physical, occupational and speech therapy. The hospices segment provides end-of-life care to patients with terminal illnesses through interdisciplinary teams of physicians, nurses, home health aides, counselors and volunteers. It offers services, including pain and symptom management, emotional and spiritual support, inpatient and respite care, homemaker services, and counseling. The LTACH locations provide services to patients with complex medical conditions who have transitioned out of a hospital intensive care unit but whose conditions remain too severe for treatment in a non-acute setting. The Company is subject to federal, state and local laws, which significantly affects its business.

Top Ranked Articles about LHC Group Inc

Insiders Roundup: Medley Capital, LHC Group Largest insider buys and sales of the week
The GuruFocus All-in-One Screener can be used to find insider trades from the past week. Under the Insiders tab, change the settings for All Insider Buying to “$200,000+,” the duration to “June 2017” and All Insider Sales to “$5,000,000+.” Read more...
Insiders Roundup: SeaWorld, Kinder Morgan, Salesforce Largest insider trades for the week of May 29
The GuruFocus All-in-One Screener can be used to find insider trades from the past week. Under the Insiders tab, change the settings for All Insider Buying to “$200,000+,” the duration to “June 2017” and “May 2017” and All Insider Sales to “$5,000,000+.” Read more...
LHC Group to Present at Jefferies 2017 Global Healthcare Conference
LHC Group again tops CMS Five-Star Quality Rating System results
LHC Group to Present at Bank of America Merrill Lynch 2017 Health Care Conference
LHC Group and Baptist Announce Joint Venture to Provide Home Health and Hospice Care
LHC Group Announces First Quarter 2017 Earnings Release and Conference Call Dates
LHC Group Announces Home Health and Hospice Joint Venture With Pleasant Valley Hospital
Archie Manning joins LHC Group as national spokesperson
LHC Group to Present at Oppenheimer 27th Annual Healthcare Conference

LAFAYETTE, La., March 20, 2017 (GLOBE NEWSWIRE) -- LHC Group, Inc. (NASDAQ:LHCG) announced today that Keith G. Myers, chief executive officer of LHC Group, will present at the Oppenheimer 27th Annual Healthcare Conference in New York on Wednesday, March 22, 2017.
The presentation will begin at 1:35 p.m. Eastern time. To access a live webcast of LHC Group’s presentation, listeners should go to the Investor Relations section of the Company’s website, www.LHCgroup.com, approximately 15 minutes prior to the event to register and download any necessary software. For those unable to listen to the live broadcast, a replay will be available for 30 days on the Company’s website. About LHC Group, Inc. LHC Group, Inc. is a national provider of non-acute healthcare services, providing quality, cost-effective healthcare to patients primarily within the comfort and privacy of their home or place of residence. LHC Group provides a comprehensive array of healthcare services through home health, hospice, community-based services agencies and facility-based services. LHC Group operates 298 home health services locations, 72 hospice locations, 16 community-based service locations and six long-term acute care hospitals (LTACHs) with eight locations. Certain matters discussed in this press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements about the Company’s future financial performance and the strength of the Company’s operations. Such forward-looking statements may be identified by words such as “continue,” “expect,” and similar expressions. Forward-looking statements involve a number of risks and uncertainties that may cause actual results to differ materially from those expressed or implied by such forward-looking statements, including changes in reimbursement, changes in government regulations, changes in LHC Group’s relationships with referral sources, increased competition for LHC Group’s services, increased competition for joint venture and acquisition candidates, changes in the interpretation of government regulations and other risks set forth in Item 1A. Risk Factors in LHC Group’s Annual Report on Form 10-K for the year ended December 31, 2016, filed with the Securities and Exchange Commission. LHC Group undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Contact:
Eric Elliott
Senior Vice President of Finance
(337) 233-1307
[email protected]

Read more...

Ratios

vs
industry
vs
history
PE Ratio 31.00
LHCG's PE Ratio is ranked lower than
60% of the 205 Companies
in the Global Medical Care industry.

( Industry Median: 26.08 vs. LHCG: 31.00 )
Ranked among companies with meaningful PE Ratio only.
LHCG' s PE Ratio Range Over the Past 10 Years
Min: 7.61  Med: 18.51 Max: 32.35
Current: 31
7.61
32.35
Forward PE Ratio 29.76
LHCG's Forward PE Ratio is ranked lower than
84% of the 63 Companies
in the Global Medical Care industry.

( Industry Median: 21.14 vs. LHCG: 29.76 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 31.00
LHCG's PE Ratio without NRI is ranked lower than
59% of the 202 Companies
in the Global Medical Care industry.

( Industry Median: 26.57 vs. LHCG: 31.00 )
Ranked among companies with meaningful PE Ratio without NRI only.
LHCG' s PE Ratio without NRI Range Over the Past 10 Years
Min: 7.62  Med: 18.33 Max: 32.35
Current: 31
7.62
32.35
Price-to-Owner-Earnings 26.02
LHCG's Price-to-Owner-Earnings is ranked higher than
52% of the 107 Companies
in the Global Medical Care industry.

( Industry Median: 27.27 vs. LHCG: 26.02 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
LHCG' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 6.64  Med: 19.86 Max: 74.26
Current: 26.02
6.64
74.26
PB Ratio 3.01
LHCG's PB Ratio is ranked lower than
57% of the 249 Companies
in the Global Medical Care industry.

( Industry Median: 2.47 vs. LHCG: 3.01 )
Ranked among companies with meaningful PB Ratio only.
LHCG' s PB Ratio Range Over the Past 10 Years
Min: 0.88  Med: 1.95 Max: 4.51
Current: 3.01
0.88
4.51
PS Ratio 1.27
LHCG's PS Ratio is ranked higher than
64% of the 257 Companies
in the Global Medical Care industry.

( Industry Median: 1.71 vs. LHCG: 1.27 )
Ranked among companies with meaningful PS Ratio only.
LHCG' s PS Ratio Range Over the Past 10 Years
Min: 0.35  Med: 0.84 Max: 2.35
Current: 1.27
0.35
2.35
Price-to-Free-Cash-Flow 17.26
LHCG's Price-to-Free-Cash-Flow is ranked higher than
67% of the 117 Companies
in the Global Medical Care industry.

( Industry Median: 24.29 vs. LHCG: 17.26 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
LHCG' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 3.89  Med: 12.84 Max: 76.05
Current: 17.26
3.89
76.05
Price-to-Operating-Cash-Flow 14.00
LHCG's Price-to-Operating-Cash-Flow is ranked higher than
55% of the 169 Companies
in the Global Medical Care industry.

( Industry Median: 15.22 vs. LHCG: 14.00 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
LHCG' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 3.67  Med: 10.1 Max: 149.26
Current: 14
3.67
149.26
EV-to-EBIT 17.91
LHCG's EV-to-EBIT is ranked higher than
60% of the 215 Companies
in the Global Medical Care industry.

( Industry Median: 20.08 vs. LHCG: 17.91 )
Ranked among companies with meaningful EV-to-EBIT only.
LHCG' s EV-to-EBIT Range Over the Past 10 Years
Min: -80.8  Med: 9.6 Max: 94.9
Current: 17.91
-80.8
94.9
EV-to-EBITDA 15.29
LHCG's EV-to-EBITDA is ranked lower than
52% of the 227 Companies
in the Global Medical Care industry.

( Industry Median: 15.13 vs. LHCG: 15.29 )
Ranked among companies with meaningful EV-to-EBITDA only.
LHCG' s EV-to-EBITDA Range Over the Past 10 Years
Min: -74.8  Med: 8.8 Max: 137.5
Current: 15.29
-74.8
137.5
PEG Ratio 0.48
LHCG's PEG Ratio is ranked higher than
92% of the 99 Companies
in the Global Medical Care industry.

( Industry Median: 3.08 vs. LHCG: 0.48 )
Ranked among companies with meaningful PEG Ratio only.
LHCG' s PEG Ratio Range Over the Past 10 Years
Min: 0.25  Med: 0.36 Max: 0.6
Current: 0.48
0.25
0.6
Shiller PE Ratio 40.07
LHCG's Shiller PE Ratio is ranked lower than
63% of the 51 Companies
in the Global Medical Care industry.

( Industry Median: 28.83 vs. LHCG: 40.07 )
Ranked among companies with meaningful Shiller PE Ratio only.
LHCG' s Shiller PE Ratio Range Over the Past 10 Years
Min: 14  Med: 23.11 Max: 41.03
Current: 40.07
14
41.03
Current Ratio 1.69
LHCG's Current Ratio is ranked higher than
61% of the 267 Companies
in the Global Medical Care industry.

( Industry Median: 1.32 vs. LHCG: 1.69 )
Ranked among companies with meaningful Current Ratio only.
LHCG' s Current Ratio Range Over the Past 10 Years
Min: 1.65  Med: 2.18 Max: 4.45
Current: 1.69
1.65
4.45
Quick Ratio 1.69
LHCG's Quick Ratio is ranked higher than
65% of the 267 Companies
in the Global Medical Care industry.

( Industry Median: 1.25 vs. LHCG: 1.69 )
Ranked among companies with meaningful Quick Ratio only.
LHCG' s Quick Ratio Range Over the Past 10 Years
Min: 1.65  Med: 2.18 Max: 4.45
Current: 1.69
1.65
4.45
Days Sales Outstanding 48.77
LHCG's Days Sales Outstanding is ranked lower than
60% of the 220 Companies
in the Global Medical Care industry.

( Industry Median: 41.13 vs. LHCG: 48.77 )
Ranked among companies with meaningful Days Sales Outstanding only.
LHCG' s Days Sales Outstanding Range Over the Past 10 Years
Min: 46.2  Med: 49.57 Max: 85.77
Current: 48.77
46.2
85.77

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -0.90
LHCG's 3-Year Average Share Buyback Ratio is ranked higher than
67% of the 141 Companies
in the Global Medical Care industry.

( Industry Median: -2.40 vs. LHCG: -0.90 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
LHCG' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -13.5  Med: -0.7 Max: 2
Current: -0.9
-13.5
2

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 1.57
LHCG's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
63% of the 98 Companies
in the Global Medical Care industry.

( Industry Median: 1.95 vs. LHCG: 1.57 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
LHCG' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.34  Med: 0.61 Max: 1.61
Current: 1.57
0.34
1.61
Price-to-Median-PS-Value 1.51
LHCG's Price-to-Median-PS-Value is ranked lower than
77% of the 230 Companies
in the Global Medical Care industry.

( Industry Median: 1.06 vs. LHCG: 1.51 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
LHCG' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.44  Med: 1.05 Max: 2.8
Current: 1.51
0.44
2.8
Earnings Yield (Greenblatt) % 5.57
LHCG's Earnings Yield (Greenblatt) % is ranked higher than
68% of the 270 Companies
in the Global Medical Care industry.

( Industry Median: 3.82 vs. LHCG: 5.57 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
LHCG' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -3.8  Med: 9.65 Max: 25.9
Current: 5.57
-3.8
25.9
Forward Rate of Return (Yacktman) % -19.34
LHCG's Forward Rate of Return (Yacktman) % is ranked lower than
91% of the 128 Companies
in the Global Medical Care industry.

( Industry Median: 10.40 vs. LHCG: -19.34 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
LHCG' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -19.34  Med: 13.6 Max: 35773.6
Current: -19.34
-19.34
35773.6

More Statistics

Revenue (TTM) (Mil) $938.89
EPS (TTM) $ 2.16
Beta0.79
Short Percentage of Float7.21%
52-Week Range $32.04 - 69.35
Shares Outstanding (Mil)18.28

Analyst Estimate

Dec17 Dec18
Revenue (Mil $) 1,035 1,130
EPS ($) 2.22 2.51
EPS without NRI ($) 2.22 2.51
EPS Growth Rate
(Future 3Y To 5Y Estimate)
15.00%
Dividends per Share ($)
» More Articles for LHCG

Headlines

Articles On GuruFocus.com
Insiders Roundup: Medley Capital, LHC Group Jun 09 2017 
Insiders Roundup: SeaWorld, Kinder Morgan, Salesforce Jun 05 2017 
LHC Group to Present at Jefferies 2017 Global Healthcare Conference Jun 05 2017 
LHC Group again tops CMS Five-Star Quality Rating System results May 10 2017 
LHC Group to Present at Bank of America Merrill Lynch 2017 Health Care Conference May 09 2017 
LHC Group and Baptist Announce Joint Venture to Provide Home Health and Hospice Care May 02 2017 
LHC Group Announces First Quarter 2017 Earnings Release and Conference Call Dates Apr 20 2017 
LHC Group Announces Home Health and Hospice Joint Venture With Pleasant Valley Hospital Apr 03 2017 
Archie Manning joins LHC Group as national spokesperson Mar 31 2017 
LHC Group to Present at Oppenheimer 27th Annual Healthcare Conference Mar 20 2017 

More From Other Websites
ETFs with exposure to LHC Group, Inc. : June 26, 2017 Jun 26 2017
Insiders Roundup: Medley Capital, LHC Group Jun 09 2017
The Zacks Analyst Blog Highlights: Gartner, NV5 Global, LHC Group, Uranium Resources and Darden... Jun 06 2017
LHC Group, Inc. :LHCG-US: Earnings Analysis: Q1, 2017 By the Numbers : June 6, 2017 Jun 06 2017
5 Stocks to Buy as Jobless Rate Hits 16-Year Low Jun 05 2017
LHC Group to Present at Jefferies 2017 Global Healthcare Conference Jun 05 2017
American Renal Associates (ARA) Looks Good: Stock Rises 8% May 12 2017
LHC Group again tops CMS Five-Star Quality Rating System results May 10 2017
LHC Group to Present at Bank of America Merrill Lynch 2017 Health Care Conference May 09 2017
Edited Transcript of LHCG earnings conference call or presentation 4-May-17 3:00pm GMT May 09 2017
LHC Group (LHCG) Shares March Higher, Can It Continue? May 09 2017
LHC tops Street 1Q forecasts May 04 2017
LHC Group Reports First Quarter 2017 EPS of $0.53 on Revenue of $246.6 Million May 03 2017
LHC Group Announces First Quarter 2017 Earnings Release and Conference Call Dates Apr 20 2017
LHC Group Announces Home Health and Hospice Joint Venture With Pleasant Valley Hospital Apr 03 2017
Blog Coverage Amedisys Acquires East Tennessee Personal Care Service to Expand its Operations in... Apr 03 2017
Archie Manning joins LHC Group as national spokesperson Mar 28 2017
Correction: Earns-LHC Group story Mar 13 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}